Individuals who developed type 1 diabetes (T1D) in adulthood faced a higher risk for all-cause mortality and major adverse cardiovascular events (MACEs) than individuals from the general population ...

Western Sydney University researchers have led a global team to pioneer a new AI-powered tool to assess the risk of developing type 1 diabetes (T1D) and predict treatment responses, potentially ...

Outside of genetics, which has a well-documented link to the risk of type 1 diabetes (T1D), investigators detail available research spanning a variety of factors, including viral infections, pesticide ...

Type 1 diabetes (T1D) is commonly diagnosed in childhood and the teen years. It’s a lifelong condition that requires treatment. Type 1 diabetes (T1D) is an autoimmune disease that occurs when the ...

VIENNA — Drugs that are already approved for other purposes are showing promise in slowing disease progression in people with new-onset type 1 diabetes (T1D), according to the results of three ...

This secondary analysis follows initial results from a phase 3 trial, which suggested that vitamin D supplementation with ergocalciferol improved insulin sensitivity, subsequently slowing the rise of ...

Scientists uncover how exposure to a mother’s type 1 diabetes during pregnancy may epigenetically “reprogram” her child’s immune system, offering new clues to lifelong protection against the disease.

SAB-142 shows favorable safety and pharmacodynamic activity in Phase 1 trial, advancing to Phase 2b for type 1 diabetes. SAB BIO announced positive results from its Phase 1 trial of SAB-142, a novel ...